Intel stock eases after 2.9 percent drop as 14A foundry progress and Q2 2026 guidance reshape the outlook
Published on 08/30/2026 at 16:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Intel Corp. (ISIN US4581401001) stock is trading below the $90 level after closing at $89.47 in the most recent session, down 2.85 percent as of August 28, 2026, while investors weigh strong Q2 2026 growth against ongoing foundry losses and ambitious 14A process plans.
Q2 2026 numbers show faster revenue growth
Per a recent earnings overview for Intel, the company reported second-quarter fiscal 2026 revenue of $16.13 billion, representing 25 percent year-over-year growth and marking one of its fastest expansions in recent years. One detailed Q2 2026 analysis notes that this acceleration was supported by higher average selling prices and better manufacturing yields.
In the same Q2 2026 report, Intel delivered earnings per share of $0.42, more than double the referenced Wall Street consensus of $0.21, indicating a positive surprise of $0.21 per share versus expectations. The company also produced a non-GAAP gross margin of 41.8 percent in the quarter, underpinned by stronger revenue and efficiency gains in its manufacturing footprint.
Operating cash flow for Q2 2026 reached $7 billion, and Intel ended the quarter with total liquidity of approximately $40 billion in cash and short-term investments, providing substantial financial flexibility to support its multi-year manufacturing roadmap.
Guidance and capital spending point to an aggressive foundry push
Looking ahead to Q3 2026, Intel guided for revenue in a range of $15.8 billion to $16.8 billion, implying a midpoint of $16.3 billion that is slightly above the just-reported Q2 2026 figure and suggests continued double-digit top-line growth. The company forecast an adjusted EPS of $0.38 for Q3 2026, paired with a targeted gross margin of 42 percent at the midpoint, signaling incremental margin improvement compared with the 41.8 percent level reported for Q2 2026. The same guidance summary also highlights plans to raise 2026 capital spending to more than $20 billion.
Intel increased its full-year 2026 capital expenditure outlook to above $20 billion from a previous range of $18 billion to $20 billion, with management indicating that most of the additional spending will go toward tooling investments in its Intel 3, 18A, and 18A-P manufacturing processes. This step-up in capital intensity underscores the importance of its foundry ambitions and next-generation process nodes for long-term growth.
Despite the strong revenue trend at the corporate level, investors remain attentive to the economics of Intel’s foundry segment. A recent report summarizing segment performance notes that Intel’s foundry operations generated Q2 2026 revenue of $5.8 billion, up 31 percent year-over-year, but still posted an operating loss of $2.1 billion for the quarter. The combination of rising foundry sales and persistent operating losses illustrates the near-term margin pressure created by large-scale process investments, even as management expects the segment to become a key profit driver once utilization and yields improve.
14A process progress and defect reduction as a key catalyst
Beyond the headline numbers, a separate conference summary dated August 30, 2026 highlights Intel’s progress on its next-generation 14A manufacturing process, a node the company positions as central to its future foundry strategy. According to that overview, Intel’s chief financial officer told investors that defect density on the 14A node is falling faster than on any process the company has developed since its highly regarded 22-nanometer technology from the early 2010s. The 14A process report emphasizes that this defect reduction trend is ahead of internal expectations.
The same 14A-focused discussion indicates that potential external foundry customers have moved from purely technical evaluations to more concrete planning around manufacturing capacity and supply timelines, with risk production for 14A expected in 2027 and high-volume manufacturing targeted for 2028. Intel’s process design kit for 14A at the 0.9 version level is expected to be released in October 2026, providing external and internal designers with the tools needed to begin building products for the node.
In parallel with the 14A progress update, Intel reaffirmed that its existing 18A process is yielding ahead of internal targets and detailed plans to expand capacity at several facilities. The company is preparing to more than double output at its Fab 52 site in Ireland next year and accelerate work at its Fab 62 facility in Arizona, underscoring the geographic breadth of its advanced-node manufacturing expansion.
Stock performance, consensus view, and recent price action
The recent share-price move has attracted attention because Intel’s stock posted exceptional returns over the past year, with one performance comparison indicating a 265 percent gain versus a 107 percent rise for a broad semiconductor exchange-traded fund over the same period. That performance comparison suggests that Intel substantially outpaced the broader chip sector over the trailing twelve months, a gap that may limit upside if growth or margins disappoint.
As of the latest session covered by recent data, Intel shares closed at $89.47, down 2.85 percent from the prior day, with the move linked to investor concerns about the scale of foundry losses and the execution risks around the 14A node and other advanced processes. Recent price history shows that this $89.47 close on August 28, 2026 came on heavy trading volume of 86.17 million shares.
A separate stock-price-focused article summarizing the same session also reports Intel’s closing price at $89.47 and frames the 2.85 percent decline in the context of challenges facing its 14A development and a reported $2.1 billion foundry loss, linking near-term share volatility to this combination of technical progress and financial strain. That stock reaction report underscores how defect reductions at 14A have improved sentiment but not fully offset concerns over the magnitude of current losses.
On the valuation side, one analyst-coverage overview notes that Intel shares presently carry a consensus rating of Hold from dozens of Wall Street analysts, with an average price target in the $107 range that implies potential upside of roughly 29 percent compared with the most recently cited price level. This consensus summary helps frame expectations: the market is broadly neutral, but analysts anticipate further gains if Intel executes on its process and foundry roadmap.
Foundry segment losses and capital allocation tension
Intel’s foundry strategy also carries an element of tension that is visible in recent segment figures. A report on its manufacturing business points out that Q2 2026 foundry revenue of $5.8 billion, up 31 percent year-over-year, still translated into an operating loss of $2.1 billion for the same period, highlighting that volume growth has not yet brought profitability. The gap between rising sales and persistent losses reflects the heavy upfront costs of process development, capacity expansion, and tooling for advanced nodes such as 18A and 14A.
At the corporate level, Intel has responded by raising its capital spending target for 2026 to $20 billion, funded in part through a significant equity offering of around $23 billion. This capital raise strengthens the balance sheet and supports long-term projects, but it also places a spotlight on management’s ability to convert these investments into durable earnings growth and attractive returns on invested capital.
For investors, the numbers create a nuanced picture. On one hand, Q2 2026 revenue growth of 25 percent and an EPS beat of $0.21 versus consensus demonstrate that Intel can deliver upside surprises when demand and execution align. On the other hand, the $2.1 billion foundry loss in Q2 2026 and the multi-year timeline for 14A high-volume manufacturing mean that profitability from new nodes is not yet assured. The interplay between these factors will likely determine whether the consensus price target in the low-$100s remains achievable.
AI and data center positioning with new GPUs
Intel’s broader AI story extends beyond manufacturing metrics. A technical conference presentation on August 24, 2026 outlined the specifications of its Crescent Island data center GPU, a product designed to focus on AI inference workloads rather than training. The Crescent Island overview describes a design featuring 32 Xe cores based on the Xe3P architecture and 256 XMX engines, paired with up to 480 GB of LPDDR5X memory in a 350-watt air-cooled PCIe card form factor.
The positioning of Crescent Island as an inference-focused accelerator complements Intel’s push to provide a full stack of data center computing solutions, from CPUs such as upcoming Diamond Rapids Xeon processors to specialized GPUs for AI workloads. For investors, the GPU launch adds another lever for revenue growth in a segment where competitors have enjoyed strong demand, and successful uptake could further support the double-digit revenue expansion seen in Q2 2026.
At the same time, Intel’s earlier decision to sell its NAND memory and storage business to SK hynix for $9 billion in 2020 is being reassessed in light of the current AI-driven memory boom, according to a recent analysis that revisits the strategic rationale of that transaction. The discussion notes that while Intel initially aimed to reinvest the proceeds in AI, 5G, and edge computing, the company’s strategy has shifted over time toward emphasizing foundry services as the main growth engine. In this context, the strong Q2 2026 revenue of $16.13 billion and growth of 25 percent year-over-year indicate that the reallocation of capital has produced broad-based gains, even if the foundry segment itself remains loss-making.
Representative product: Crescent Island AI inference GPU
One representative product that illustrates Intel’s current direction is the Crescent Island data center GPU for AI inference. As described in the Hot Chips 2026 presentation, the card combines 32 Xe cores with 256 XMX engines and supports up to 480 GB of LPDDR5X memory, all within a 350-watt air-cooled PCIe design tailored to data center deployment. By optimizing for inference workloads, Crescent Island aims to deliver high throughput and low latency on models that have already been trained, aligning with demand from cloud providers and enterprises seeking efficient AI inference capacity.
Stock level below $90 as investors digest Q2 2026 and 14A goals
Intel stock’s close at $89.47 on August 28, 2026, down 2.85 percent on volume of 86.17 million shares, places the shares below the $90 threshold as the market digests Q2 2026 results, expanded capital spending plans, and fresh detail on 14A process progress. The combination of a 25 percent year-over-year revenue increase to $16.13 billion and a $2.1 billion Q2 2026 foundry operating loss illustrates the trade-off between near-term profitability and long-term manufacturing leadership that investors will continue to monitor.
Read more
More on Intel stock and its manufacturing and AI roadmap can be found through the latest detailed coverage of its Q2 2026 earnings, guidance ranges, and foundry investments, which collectively highlight the company’s efforts to balance capital intensity with margin recovery.
Fact box
Company: Intel Corp.
ISIN: US4581401001
Ticker: INTC
Exchange: Nasdaq
Price (as of August 28, 2026, 4:00 p.m. ET): $89.47 USD
Market cap: value based on latest close
Sector / Industry: Information Technology / Semiconductors
Index membership: S&P 500
